BIO•STATISTICS was founded in 2001 and since its foundation, the company has collaborated with 17 Greek and Multinational pharmaceutical companies and 12 Healthcare Institutions and Hospitals, providing clinical research services in 127 clinical and epidemiological research projects, including clinical trials, Delphi consensus studies and other bio-medical projects. Since 2016, it has been exclusively focused on the field of RWE. In February 2026, BIO•STATISTICS was certified to ISO 9001:2015and ISO 14001:2015 for its Quality and Environmental Management Systems, respectively, covering its activities as a Contract Research Organization (CRO) specializing in non-interventional studies (NIS) and epidemiological studies. In August 2026 our Company was assessed by EcoVadis for its Environmental, Social, and Governance (ESG) performance and was awarded a Platinum Medal, placing it among the top 1% of companies assessed globally. Our services aim to support the collaboration between healthcare and scientific organizations and pharmaceutical companies, as well as the implementation and dissemination of their scientific work.